CTMX vs ETN · rev $11.7M vs P/E 39, rev $15.98B
CytomX Therapeutics Inc (CTMX) versus Eaton Corporation PLC (ETN) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Eaton Corporation PLC (ETN) is a specialty industrial machinery company listed on US.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported ETN revenue for 2026-06-30 was $15.98B. Net income was $1.69B. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
CTMX currently screens at market cap $653.1M. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
Not investment advice. Open the CTMX and ETN stock pages for the full models.
Not investment advice.